Creating state-of-the-art facilities for drug discovery and development

The drug discovery and development sector faces significant challenges, including rising costs, lengthy development timelines and increasing pressure to deliver more sustainable approaches to research. At the University of Strathclyde, we are tackling these challenges through innovation, collaboration and philanthropy.

In 2026, we proudly opened the Sir David Jack Hub within the Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS). Named in honour of one of Strathclyde's most distinguished alumni and pioneering pharmaceutical scientists, Sir David Jack, the Hub provides a multidisciplinary, sustainable and accessible environment designed to accelerate breakthroughs in biomedical research.

Equipped with advanced cell culture and analysis technologies, the Hub enables researchers and students to investigate disease, develop more realistic models of human biology and evaluate potential new treatments. By bringing together expertise from across scientific disciplines, it supports the collaborative approach that was central to Sir David's own success and is fundamental to tackling today's global health challenges.

The Hub underpins critical research into conditions such as cancer, diabetes, cardiovascular disease, dementia and inflammatory disorders, while also providing students with hands-on experience of the technologies and methodologies shaping the future of biomedical science.

The opening of the Sir David Jack Hub marks a major milestone, but it is only the beginning of an ambitious long-term vision. As research needs evolve and new technologies emerge, we will continue to enhance the Hub's capabilities through investment in additional equipment, facilities and specialist resources. Ongoing philanthropic support will help ensure that researchers and students have access to the latest technologies, enabling ever-greater scientific discovery and impact.

The Hub has been made possible through the generosity of Sir David Jack's legacy and a community of visionary philanthropic supporters who share our commitment to improving health and wellbeing through research and innovation.

By supporting the continued development of the Sir David Jack Hub, donors can help create new opportunities for discovery, equip future generations of scientists and accelerate the development of treatments that could improve lives around the world.

If you are interested in learning more about the Hub or making a gift in support of its future development, please contact Kirsten Wols, Development Manager, at Kirsten.Wols@strath.ac.uk or the Development Office at developmentoffice@strath.ac.uk.

If you are based in the US, please contact the University of Strathclyde USA Foundation, an independent charitable corporation with 501(c)(3) status, via alumni@strath.ac.uk.

Your support will help ensure that the Sir David Jack Hub remains at the forefront of biomedical innovation, delivering benefits for researchers, students and ultimately the patients and communities whose lives depend on scientific progress.